Trials / Completed
CompletedNCT00432198
Zolpidem Postmarketing Study in Adolescent Patients With Insomnia
Zolpidem Postmarketing Clinical Study: A Double Blind, Placebo Controlled Group Comparative Trial in the Adolescent Patients With Insomnia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the efficacy and safety of zolpidem for pediatric insomniacs in a randomized double blind-controlled trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zolpidem (Myslee®) | Oral |
| DRUG | placebo | Oral |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2007-02-07
- Last updated
- 2017-02-17
Locations
7 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00432198. Inclusion in this directory is not an endorsement.